Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis

Jannatul Ferdoush, Saswati Karmakar, Priyanka Barman, Amala Kaja, Bhawana Uprety, Surinder Kumar Batra, Sukesh R. Bhaumik

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The evolutionarily conserved RNA polymerase II-associated factor 1 (Paf1) from yeast to humans regulates transcription and associated processes, and thus, malfunctions and/or misregulations of Paf1 are associated with cellular pathologies. Indeed, Paf1 (also known as PD2 or pancreatic differentiation 2) is found to be upregulated in poorly differentiated cancer cells, and such upregulation is involved in cellular transformation or oncogenesis. However, the basis for Paf1 upregulation in these cells remains largely unknown. In light of this, we have tested here the idea that the ubiquitin-proteasome system (UPS) regulates the cellular abundance of Paf1. In this direction, we analyzed the role of UPS in regulation of Paf1's abundance in yeast. We find that Paf1 undergoes ubiquitylation and is degraded by the 26S proteasome in yeast, thus deciphering UPS regulation of an evolutionarily conserved factor, Paf1, involved in various cellular processes at the crossroads of the cancer networks. Likewise, Paf1 undergoes proteasomal degradation in well-differentiated, but not poorly differentiated, pancreatic cancer cells, hence pointing to the UPS in upregulation of Paf1 in poorly differentiated cancers. Collectively, our results reveal UPS regulation of Paf1 and suggest downregulation of UPS in elevating Paf1's abundance in poorly differentiated cancers.

Original languageEnglish (US)
Pages (from-to)6083-6086
Number of pages4
JournalBiochemistry
Volume56
Issue number46
DOIs
StatePublished - Nov 21 2017

Fingerprint

RNA Polymerase II
Proteasome Endopeptidase Complex
Ubiquitin
Carcinogenesis
Yeast
Up-Regulation
Yeasts
Neoplasms
Cells
Ubiquitination
Pathology
Transcription
Pancreatic Neoplasms
Down-Regulation
Degradation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis. / Ferdoush, Jannatul; Karmakar, Saswati; Barman, Priyanka; Kaja, Amala; Uprety, Bhawana; Batra, Surinder Kumar; Bhaumik, Sukesh R.

In: Biochemistry, Vol. 56, No. 46, 21.11.2017, p. 6083-6086.

Research output: Contribution to journalArticle

Ferdoush, Jannatul ; Karmakar, Saswati ; Barman, Priyanka ; Kaja, Amala ; Uprety, Bhawana ; Batra, Surinder Kumar ; Bhaumik, Sukesh R. / Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis. In: Biochemistry. 2017 ; Vol. 56, No. 46. pp. 6083-6086.
@article{c6f423a22a09489cbc92c939a8260e0d,
title = "Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis",
abstract = "The evolutionarily conserved RNA polymerase II-associated factor 1 (Paf1) from yeast to humans regulates transcription and associated processes, and thus, malfunctions and/or misregulations of Paf1 are associated with cellular pathologies. Indeed, Paf1 (also known as PD2 or pancreatic differentiation 2) is found to be upregulated in poorly differentiated cancer cells, and such upregulation is involved in cellular transformation or oncogenesis. However, the basis for Paf1 upregulation in these cells remains largely unknown. In light of this, we have tested here the idea that the ubiquitin-proteasome system (UPS) regulates the cellular abundance of Paf1. In this direction, we analyzed the role of UPS in regulation of Paf1's abundance in yeast. We find that Paf1 undergoes ubiquitylation and is degraded by the 26S proteasome in yeast, thus deciphering UPS regulation of an evolutionarily conserved factor, Paf1, involved in various cellular processes at the crossroads of the cancer networks. Likewise, Paf1 undergoes proteasomal degradation in well-differentiated, but not poorly differentiated, pancreatic cancer cells, hence pointing to the UPS in upregulation of Paf1 in poorly differentiated cancers. Collectively, our results reveal UPS regulation of Paf1 and suggest downregulation of UPS in elevating Paf1's abundance in poorly differentiated cancers.",
author = "Jannatul Ferdoush and Saswati Karmakar and Priyanka Barman and Amala Kaja and Bhawana Uprety and Batra, {Surinder Kumar} and Bhaumik, {Sukesh R.}",
year = "2017",
month = "11",
day = "21",
doi = "10.1021/acs.biochem.7b00865",
language = "English (US)",
volume = "56",
pages = "6083--6086",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "46",

}

TY - JOUR

T1 - Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis

AU - Ferdoush, Jannatul

AU - Karmakar, Saswati

AU - Barman, Priyanka

AU - Kaja, Amala

AU - Uprety, Bhawana

AU - Batra, Surinder Kumar

AU - Bhaumik, Sukesh R.

PY - 2017/11/21

Y1 - 2017/11/21

N2 - The evolutionarily conserved RNA polymerase II-associated factor 1 (Paf1) from yeast to humans regulates transcription and associated processes, and thus, malfunctions and/or misregulations of Paf1 are associated with cellular pathologies. Indeed, Paf1 (also known as PD2 or pancreatic differentiation 2) is found to be upregulated in poorly differentiated cancer cells, and such upregulation is involved in cellular transformation or oncogenesis. However, the basis for Paf1 upregulation in these cells remains largely unknown. In light of this, we have tested here the idea that the ubiquitin-proteasome system (UPS) regulates the cellular abundance of Paf1. In this direction, we analyzed the role of UPS in regulation of Paf1's abundance in yeast. We find that Paf1 undergoes ubiquitylation and is degraded by the 26S proteasome in yeast, thus deciphering UPS regulation of an evolutionarily conserved factor, Paf1, involved in various cellular processes at the crossroads of the cancer networks. Likewise, Paf1 undergoes proteasomal degradation in well-differentiated, but not poorly differentiated, pancreatic cancer cells, hence pointing to the UPS in upregulation of Paf1 in poorly differentiated cancers. Collectively, our results reveal UPS regulation of Paf1 and suggest downregulation of UPS in elevating Paf1's abundance in poorly differentiated cancers.

AB - The evolutionarily conserved RNA polymerase II-associated factor 1 (Paf1) from yeast to humans regulates transcription and associated processes, and thus, malfunctions and/or misregulations of Paf1 are associated with cellular pathologies. Indeed, Paf1 (also known as PD2 or pancreatic differentiation 2) is found to be upregulated in poorly differentiated cancer cells, and such upregulation is involved in cellular transformation or oncogenesis. However, the basis for Paf1 upregulation in these cells remains largely unknown. In light of this, we have tested here the idea that the ubiquitin-proteasome system (UPS) regulates the cellular abundance of Paf1. In this direction, we analyzed the role of UPS in regulation of Paf1's abundance in yeast. We find that Paf1 undergoes ubiquitylation and is degraded by the 26S proteasome in yeast, thus deciphering UPS regulation of an evolutionarily conserved factor, Paf1, involved in various cellular processes at the crossroads of the cancer networks. Likewise, Paf1 undergoes proteasomal degradation in well-differentiated, but not poorly differentiated, pancreatic cancer cells, hence pointing to the UPS in upregulation of Paf1 in poorly differentiated cancers. Collectively, our results reveal UPS regulation of Paf1 and suggest downregulation of UPS in elevating Paf1's abundance in poorly differentiated cancers.

UR - http://www.scopus.com/inward/record.url?scp=85034776721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034776721&partnerID=8YFLogxK

U2 - 10.1021/acs.biochem.7b00865

DO - 10.1021/acs.biochem.7b00865

M3 - Article

C2 - 29023102

AN - SCOPUS:85034776721

VL - 56

SP - 6083

EP - 6086

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 46

ER -